tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Cardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
RatingsCardiol Therapeutics: Strong Buy Rating Backed by Promising CardiolRx Trial Results and Strategic Growth Potential
17d ago
CRDL
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
PremiumTipRanks Newswire
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions
17d ago
CRDL
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
PremiumCompany Announcements
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™
17d ago
6K
CRDL
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress
PremiumCompany Announcements
Cardiol Therapeutics Reports Financial Challenges Amid Clinical Progress
22d ago
CRDL
Cardiol Therapeutics: Promising Pipeline and Financial Stability Support Buy Rating
PremiumRatings
Cardiol Therapeutics: Promising Pipeline and Financial Stability Support Buy Rating
1M ago
CRDL
Cardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease
PremiumCompany AnnouncementsCardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease
1M ago
6K
CRDL
Cardiol Therapeutics Secures U.S. Patent for Heart Drugs
Premium
Company Announcements
Cardiol Therapeutics Secures U.S. Patent for Heart Drugs
1M ago
6K
CRDL
Cardiol Therapeutics to Present Promising ARCHER Trial Results at ESC Meeting
Premium
Company Announcements
Cardiol Therapeutics to Present Promising ARCHER Trial Results at ESC Meeting
1M ago
CRDL
Cardiol Therapeutics Raises $16 Million Through Recent Securities Distribution
PremiumCompany Announcements
Cardiol Therapeutics Raises $16 Million Through Recent Securities Distribution
2M ago
6K
CRDL
Cardiol Therapeutics Secures $11 Million to Advance Heart Disease Therapies
PremiumCompany Announcements
Cardiol Therapeutics Secures $11 Million to Advance Heart Disease Therapies
2M ago
6K
CRDL
Cardiol Therapeutics Secures $11.4M Financing to Fund Heart Disease Therapies
PremiumCompany Announcements
Cardiol Therapeutics Secures $11.4M Financing to Fund Heart Disease Therapies
2M ago
6K
CRDL
Cardiol Therapeutics Secures $11M Financing, Advances Heart Disease Therapies
PremiumCompany Announcements
Cardiol Therapeutics Secures $11M Financing, Advances Heart Disease Therapies
2M ago
CRDL
Cardiol Therapeutics trading resumes
PremiumThe FlyCardiol Therapeutics trading resumes
2M ago
CRDL
Cardiol Therapeutics trading halted, news pending
Premium
The Fly
Cardiol Therapeutics trading halted, news pending
2M ago
CRDL
Cardiol Therapeutics: Promising Developments in Cardiac Disease Treatment with CardiolRx
Premium
Ratings
Cardiol Therapeutics: Promising Developments in Cardiac Disease Treatment with CardiolRx
4M ago
CRDL
Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses
PremiumCompany Announcements
Cardiol Therapeutics Reports Q2 2025 Financial Results Amid Rising Losses
4M ago
6K
CRDL
Cardiol Therapeutics to Present at Canaccord Genuity Conference
PremiumCompany Announcements
Cardiol Therapeutics to Present at Canaccord Genuity Conference
4M ago
CRDL
Roth bullish on Cardiol, says trial results enough to attract larger partner
PremiumThe Fly
Roth bullish on Cardiol, says trial results enough to attract larger partner
4M ago
CRDL
Optimistic Buy Rating for Cardiol Therapeutics Amid Promising Clinical Trial Results and Strategic Advancements
PremiumRatings
Optimistic Buy Rating for Cardiol Therapeutics Amid Promising Clinical Trial Results and Strategic Advancements
4M ago
CRDL
Cardiol ARCHER study not statistically significant, says Canaccord
PremiumThe FlyCardiol ARCHER study not statistically significant, says Canaccord
4M ago
CRDL
Cardiol falls 14% to $1.16 after myocarditis study results
Premium
The Fly
Cardiol falls 14% to $1.16 after myocarditis study results
4M ago
CRDL
Cardiol data readout positive and not priced in, says H.C. Wainwright
Premium
The Fly
Cardiol data readout positive and not priced in, says H.C. Wainwright
4M ago
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >